Enhancing acupuncture by low dose naltrexone

Low-Dose Naltrexone in Diseases' Treatment: Global Review

Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis

BMC Immunol
24 April 2015
https://pubmed.ncbi.nlm.nih.gov/25906771/

Duration of opioid receptor blockade determines biotherapeutic response

J Clin Gastroenterol
October 2015
https://pubmed.ncbi.nlm.nih.gov/26119823/

Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability

J Clin Gastroenterol
October 2015
https://pubmed.ncbi.nlm.nih.gov/26203498/

Treatment of clinically isolated syndrome with Low Dose Naltrexone

Clin Case Rep Rev
January 2015
http://www.oatext.com/pdf/CCRR-1-161.pdf

Opioid growth factor and low dose naltrexone impair central nervous system infiltration by CD4+T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis

Exp Biol Med (Maywood)
January 2016
http://www.ncbi.nlm.nih.gov/pubmed/26202376

Potential drug interaction with opioid agonist in the setting of chronic low-dose opioid antagonist use

Am J Emerg Med
August 2017
https://pubmed.ncbi.nlm.nih.gov/28410920/